Press Releases

Principle Health Systems, the leading provider of mobile laboratory services to long-term care facilities in Texas, is proud to announce the acquisition of BioStat Imaging, a mobile imaging provider based in Dallas, Texas. This strategic acquisition underscores Principle's commitment to offering comprehensive, high-quality diagnostic services to the long-term care community. As the premier laboratory service provider for long-term care facilities in Texas, Principle Health Syste

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced the enrollment completion of the Omny-IRE clinical trial. Omny-IRE is a prospective, multi-center, non-randomized clinical trial that enrolled 188 patients in Europe and Canada to evaluate the safety and effectiveness of the Biosense Webster OMNYPULSE™ Platform for the mapping and treatment of symptomatic paroxysmal atrial fibrillation (AFib) during standard abla

MicroPort® CRM, a pioneering company in the field of Cardiac Rhythm management, headquartered in France, announces it has received an expanded labeling for its latest range of implantable pacemakers, ALIZEA™, BOREA™ and CELEA™, for Left Bundle Branch Area Pacing (LBBAP). LBBAP, utilizing the heart's natural conduction system efficiency, is recognized as the new approach to physiological pacing.1 "Our latest generation of Bluetooth pacemakers

GEM SLEEP, the leading virtual sleep apnea clinic, is proud to announce the launch of its enhanced portal experience, designed to streamline the treatment selection process for patients. This update brings transparency to the options associated with obstructive sleep apnea (OSA) treatments, empowering patients to make informed decisions with confidence. For many patients, getting started with treatment for OSA can be a daunting task, compounded by confusion over the cost, complexity

Centinel Spine®, LLC (“the Company”), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced data supporting strong market growth and the long-term durability and reliability of the lumbar total disc replacement (LTDR) procedure. Data from a landmark long-term LTDR study out of

MedRhythms, Inc. today announced that the Centers for Medicare and Medicaid Services (CMS) established a new reimbursement code for the company's flagship product, InTandem, the only clinically validated, prescription medical device that delivers rhythmic auditory stimulation (RAS) in the home to improve walking and ambulation in chronic stroke patients. In its final determination, CMS established a new HCPCS code to describe InTandem: E3200 (gait modulation system, rhythmic aud

WellSky, a leading health and community care technology company, today announced the expansion of its partnership with Atlantic Health System (Atlantic Health), a premier provider of healthcare in New Jersey. Building on the successful implementation of real-time post-acute performance analytics solution, CarePort Insight, in 2021, Atlantic Health is further strengthening care coordination and patient management across the healthcare continuum with CarePort Connect. With 35 in-netwo

Healthcare leaders from across the Asia Pacific region have come together for the InterSystems Asia Healthcare Summit, featuring an AI and Connected Care Symposium designed to help healthcare leaders navigate a future shaped by data and AI-enabled care. The summit, from August 21-22 in Jakarta, advanced data-enabled healthcare initiatives across the Asia Pacific region, with a particular focus on Indonesia’s rapidly evolving healthcare landscape. The opening day of the summit

Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced that the Froedtert & the Medical College of Wisconsin health network is now screening patients with IntelliSep® in a pilot at its flagship hospital, Froedtert Hospital in Milwaukee. IntelliSep is the first U.S. Food and Drug Administration (FDA)-cleared rapid diagnostic test for the early detection of seps

Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announces that a long standing healthcare client based in California has expanded its contract subscribing to another K5 Autonomous Security Robot (“ASR”). The client originally deployed their first K5 ASR in 2023 and, based off that success, it was decided that a second robot